Tci Wealth Advisors, Inc. Vaxart, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$2.09 - $4.5 $209 - $450	100 Added 25.0%	500 $1,000
Q1 2022 Apr 29, 2022	SELL	$4.29 - $6.64 $2,831 - $4,382	-660 Reduced 62.26%	400 $2,000
Q4 2021 Jan 24, 2022	BUY	$5.77 - $7.96 $1,113 - $1,536	193 Added 22.26%	1,060 $7,000
Q3 2021 Oct 29, 2021	BUY	$6.67 - $9.8 $2,447 - $3,596	367 Added 73.4%	867 $7,000
Q2 2021 Aug 02, 2021	BUY	$5.06 - $10.78 $505 - $1,078	100 Added 25.0%	500 $4,000
Q4 2020 Jan 21, 2021	BUY	$3.5 - $7.98 $350 - $798	100 Added 33.33%	400 $2,000
Q3 2020 Oct 20, 2020	BUY	$4.78 - $16.97 $1,434 - $5,091	300 New	300 $2,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.